Please find enclosed herewith the Financial Results for the year ended 31st March, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 9.3 pts less than Nifty Microcap 250 and 8.0 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Royal Sense Limited reported strong revenue growth with consolidated revenue from operations rising 67.4% to Rs 10,337.59 lakhs (FY26) from Rs 6,173.40 lakhs (FY25). Standalone revenue grew 36.7% to Rs 3,778.57 lakhs. However, standalone PAT declined marginally to Rs 301.24 lakhs from Rs 304.49 lakhs (–1.1%), indicating margin compression. On a consolidated basis, PAT surged 162.5% to Rs 657.20 lakhs, boosted by the wholly-owned subsidiary Stergic Retail Private Limited (contributing Rs 416.76 lakhs to consolidated PAT). The auditors issued unmodified opinions on both standalone and consolidated financial statements. The company also raised share warrants in December 2025, receiving Rs 607.73 lakhs, of which Rs 247.57 lakhs has been utilised for working capital and general corporate purposes as certified by the auditors.
Revenue growth is impressive and the subsidiary is a strong earnings contributor, but the sharp decline in standalone PAT and the substantial negative operating cash flow (standalone: –Rs 357.72 lakhs; consolidated: –Rs 1,328.56 lakhs) despite profitable operations signals working capital stress that investors should monitor closely.